JP2019514913A5 - - Google Patents

Download PDF

Info

Publication number
JP2019514913A5
JP2019514913A5 JP2018556332A JP2018556332A JP2019514913A5 JP 2019514913 A5 JP2019514913 A5 JP 2019514913A5 JP 2018556332 A JP2018556332 A JP 2018556332A JP 2018556332 A JP2018556332 A JP 2018556332A JP 2019514913 A5 JP2019514913 A5 JP 2019514913A5
Authority
JP
Japan
Prior art keywords
agent
optionally
polypeptide
antibody
adhesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018556332A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019514913A (ja
JP7160683B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/030454 external-priority patent/WO2017190148A1/en
Publication of JP2019514913A publication Critical patent/JP2019514913A/ja
Publication of JP2019514913A5 publication Critical patent/JP2019514913A5/ja
Application granted granted Critical
Publication of JP7160683B2 publication Critical patent/JP7160683B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018556332A 2016-04-29 2017-05-01 術後癒着の予防及び治療のための方法及び組成物 Active JP7160683B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662329666P 2016-04-29 2016-04-29
US62/329,666 2016-04-29
PCT/US2017/030454 WO2017190148A1 (en) 2016-04-29 2017-05-01 Methods and compositions for the prevention and treatment of surgical adhesions

Publications (3)

Publication Number Publication Date
JP2019514913A JP2019514913A (ja) 2019-06-06
JP2019514913A5 true JP2019514913A5 (https=) 2020-05-28
JP7160683B2 JP7160683B2 (ja) 2022-10-25

Family

ID=60161169

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018556332A Active JP7160683B2 (ja) 2016-04-29 2017-05-01 術後癒着の予防及び治療のための方法及び組成物

Country Status (9)

Country Link
US (1) US10934355B2 (https=)
EP (1) EP3448421B1 (https=)
JP (1) JP7160683B2 (https=)
CA (1) CA3019841A1 (https=)
ES (1) ES2903210T3 (https=)
PL (1) PL3448421T3 (https=)
PT (1) PT3448421T (https=)
SI (1) SI3448421T1 (https=)
WO (1) WO2017190148A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108795867A (zh) * 2018-06-05 2018-11-13 华东理工大学 用于构建结肠癌细胞腹膜转移体外三维模型的方法
US11591390B2 (en) 2018-09-27 2023-02-28 Celgene Corporation SIRP-α binding proteins and methods of use thereof
SG11202102851XA (en) 2018-09-27 2021-04-29 Celgene Corp SIRPa BINDING PROTEINS AND METHODS OF USE THEREOF
EP3917515A1 (en) 2019-01-29 2021-12-08 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Treating the causative agent in adhesiogenesis
US20200386772A1 (en) * 2019-06-05 2020-12-10 Mark D. Noar Method For Detecting Bodily Adhesions By Identifying Markers In Circulating Cells
CN115569196B (zh) * 2020-02-26 2024-06-18 上海科技大学 多酚类物质在抗冠状病毒中的应用
WO2022126259A1 (en) * 2020-12-14 2022-06-23 Uti Limited Partnership Treatment of peritoneal, pleural, and pericardium adhesions
US20220233135A1 (en) * 2021-01-22 2022-07-28 Ethicon Llc Prediction of adhesions based on biomarker monitoring
US12543982B2 (en) 2021-01-22 2026-02-10 Cilag Gmbh International Method of adjusting a surgical parameter based on biomarker measurements
US12011163B2 (en) 2021-01-22 2024-06-18 Cilag Gmbh International Prediction of tissue irregularities based on biomarker monitoring
US12440285B2 (en) 2021-01-22 2025-10-14 Cilag Gmbh International Prediction of hemostasis issues based on biomarker monitoring
CN113244400B (zh) * 2021-05-21 2022-12-16 华北理工大学 一种C5aRA在制备治疗和/或预防腹腔粘连的产品中的应用
KR20240099431A (ko) * 2021-11-05 2024-06-28 헬름홀츠 젠트룸 뮌헨-도이체스 포르슝스젠트룸 퓌르 게준드하이트 운트 움벨트 게엠베하 중피 ecm 이동의 조절제

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985660A (en) 1994-06-15 1999-11-16 Systemix, Inc. Method of identifying biological response modifiers involved in dendritic and/or lymphoid progenitor cell proliferation and/or differentiation
US5639468A (en) 1995-06-07 1997-06-17 University Of Southern California Method for reducing or preventing post-surgical adhesion formation using manoalide and analogs thereof
JP2001520201A (ja) 1997-10-16 2001-10-30 ネーデルランセ オルハニサチエ フォール トゥーヘパスト−ナツールウェーテンシャッペルック オンデルズク テーエヌオー 癒着形成の予防と処置
US6812220B2 (en) 2001-08-29 2004-11-02 University Of British Columbia Pharmaceutical compositions and methods relating to fucans
DE60310383T2 (de) 2002-01-29 2007-09-20 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw. Vorbeugung von gewebeadhäsion
US20040131600A1 (en) 2002-03-11 2004-07-08 Diamond Michael P. Method of preventing adhesions by apoptosis of adhesion peritoneal cells
JP4224586B2 (ja) 2004-04-28 2009-02-18 国立大学法人群馬大学 マクロファージ活性化剤並びにその製造方法及びスクリーニング方法
US20080045463A1 (en) 2004-10-25 2008-02-21 Ajay Verma Methods For Lowering Hif-1 Mediated Gene Expression
CA2600505C (en) 2005-03-10 2016-05-03 Morphotek, Inc. Anti-mesothelin antibodies
EP1891141B1 (en) 2005-05-31 2016-11-16 Ecole Polytechnique Fédérale de Lausanne (EPFL) Triblock copolymers for cytoplasmic delivery of gene-based drugs
PT1940439E (pt) 2005-08-11 2010-12-17 Univ Saskatchewan Redução da formação de aderências pós-operatórias com glutamina intraperitoneal
CA2658584A1 (en) * 2006-07-27 2008-01-31 Ottawa Health Research Institute Staged immune-response modulation in oncolytic therapy
CA2700860C (en) * 2007-10-01 2016-07-19 Jonathan A. Terrett Human antibodies that bind mesothelin, and uses thereof
AU2009205665B2 (en) 2008-01-15 2013-12-05 The Board Of Trustees Of The Leland Stanford Junior University Methods for manipulating phagocytosis mediated by CD47
ES2325724B1 (es) 2008-03-11 2010-05-31 FUNDACION DE LA COMUNIDAD VALENCIANA "CENTRO DE INVESTIGACIONES PRINCIPE FELIPE" Composicion farmaceutica para inhibir el factor de transcripcion inducible por hipoxia. moduladores de procesos patologicos de angiogenesis, oncogenesis, inflamacion, apoptosis y terapia celular.
US8460660B2 (en) * 2009-03-24 2013-06-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Anti-mesothelin antibodies
EP2477648B1 (en) 2009-09-15 2022-07-20 The Board of Trustees of the Leland Stanford Junior University Synergistic anti-cd47 therapy for hematologic cancers
JP2011195574A (ja) 2010-02-25 2011-10-06 Kwansei Gakuin ビスフェノールa誘導体を含有するhif阻害剤
SI2804617T1 (sl) * 2012-01-17 2020-10-30 The Board Of Trustees Of The Leland Stanford Junior University Visokoafinitetni SIRP-alfa reagenti
US8962577B2 (en) 2012-03-16 2015-02-24 The Johns Hopkins University Controlled release formulations for the delivery of HIF-1 inhibitors
PT2970493T (pt) 2013-03-15 2019-06-27 Univ Leland Stanford Junior Métodos para obter doses terapeuticamente eficazes de agentes anti-cd47

Similar Documents

Publication Publication Date Title
JP2019514913A5 (https=)
Tripathi et al. HMGB1 protein as a novel target for cancer
Meng et al. Capturing cytokines with advanced materials: a potential strategy to tackle COVID‐19 cytokine storm
JP2006525796A5 (https=)
EP3448421B1 (en) Methods and compositions for the prevention and treatment of surgical adhesions
da Silva et al. Induction of TNF-alfa and CXCL-2 mRNAs in different organs of mice infected with pathogenic Leptospira
JP2006513992A5 (https=)
JP2011519277A5 (https=)
JP2004533444A5 (https=)
Chen et al. Age-related alterations in immune function and inflammation: focus on ischemic stroke
Grist et al. Neutrophils and viral-induced neurologic disease
EP3606559A1 (en) Bioorthogonal compositions
Cirelli et al. AAV2/1-TNFR: Fc gene delivery prevents periodontal disease progression
JP2012522508A5 (https=)
Atluri et al. Vorinostat positively regulates synaptic plasticity genes expression and spine density in HIV infected neurons: role of nicotine in progression of HIV-associated neurocognitive disorder
JPH11504036A (ja) ケモカイン結合タンパク質およびその使用
JP2013504603A5 (https=)
Messora et al. Rosuvastatin promotes benefits on induced periodontitis in hypertensive rats
Zhu et al. Low‐intensity pulsed ultrasound alleviates doxorubicin‐induced cardiotoxicity via inhibition of S100a8/a9‐mediated cardiac recruitment of neutrophils
JP2010513308A (ja) 血管新生向性ペプチド
Saito et al. The CC chemokine ligand (CCL) 1, upregulated by the viral transactivator Tax, can be downregulated by minocycline: possible implications for long-term treatment of HTLV-1-associated myelopathy/tropical spastic paraparesis
CN103371989A (zh) 黄腐酚在制备抑制破骨细胞分化和蚀骨功能的预防和/或治疗药物中的应用
Ritzenthaler et al. The integrin inhibitor cilengitide and bleomycin-induced pulmonary fibrosis: cilengitide and bleomycin-induced pulmonary fibrosis
JP4744443B2 (ja) 毒素中和性ペプチドのスクリーニング方法とstx2阻害性ペプチド並びにベロ毒素中和剤
Yang et al. Emerging nanomaterials applied for tackling the COVID-19 cytokine storm